Outcomes based on plasma biomarkers for the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (aHCC) Meeting Abstract
| Authors: | Parnis, F.; Rimassa, L.; Kelley, R. K.; Meyer, T.; Ryoo, B. Y.; Merle, P.; Park, J. W.; Blanc, J. F.; Lim, H. Y.; Tran, A.; Borgman-Hagey, A. E.; Clary, D. O.; Wang, E.; Cheng, A. L.; El-Khoueiry, A. B.; Abou-Alfa, G. K. |
| Abstract Title: | Outcomes based on plasma biomarkers for the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (aHCC) |
| Meeting Title: | 46th Annual Scientific Meeting of the Clinical Oncology Society of Australia (COSA) |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 15 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2019 Nov 12-14 |
| Meeting Location: | Adelaide, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2019-11-01 |
| Start Page: | 180 |
| End Page: | 181 |
| Language: | English |
| ACCESSION: | WOS:000493438400291 |
| PROVIDER: | wos |
| PUBMED: | 31674106 |
| DOI: | 10.1111/ajco.13263 |
| Notes: | Meeting Abstract: 340 -- Source: Wos |
